Vortioxetine improves gastrointestinal motility and reduces intestinal inflammation in a cuprizone-induced multiple sclerosis model in mice. (2026). Annals of Medical Research, 33(5), 192-198. http://www.annalsmedres.org/index.php/aomr/article/view/4909